- Home
- TFX
as 03-14-2025 4:00pm EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
| Founded: | 1943 | Country: | United States |
| Employees: | N/A | City: | WAYNE |
| Market Cap: | 8.3B | IPO Year: | N/A |
| Target Price: | $193.88 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.48 | EPS Growth: | -80.36 |
| 52 Week Low/High: | $128.55 - $249.91 | Next Earning Date: | 05-01-2025 |
| Revenue: | $3,047,324,000 | Revenue Growth: | 2.45% |
| Revenue Growth (this year): | 3.37% | Revenue Growth (next year): | 4.13% |
Latest Teleflex Incorporated News
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
DoorDash, TKO, Williams-Sonoma Set to Join S&P 500
Simply Wall St.
7 days ago
Teleflex's (NYSE:TFX) Soft Earnings Don't Show The Whole Picture
Motley Fool
7 days ago
Teleflex Announces Split Into 2 Public Companies
MT Newswires
11 days ago
Morgan Stanley Adjusts Price Target on Teleflex to $191 From $275, Keeps Overweight Rating
Argus Research
12 days ago
TFX: Lowering target price to $137.00
MT Newswires
12 days ago
BofA Securities Downgrades Teleflex to Underperform From Neutral
Insider Monkey
15 days ago
Why Teleflex Incorporated (TFX) Went Down On Friday?
MT Newswires
16 days ago
Truist Cuts Price Target on Teleflex to $149 From $200, Keeps Hold Rating
Compare TFX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.